The days of the high-margin “blockbuster” are over; the competition from generics manufacturers is intense; and the products that the life sciences industry makes are becoming increasingly complex. So unlocking the full value of the supply chain is now more important than ever.
Yet providing an efficient, reliable and cost-effective and tax efficient supply chain presents small and mid-sized life sciences companies with many challenges. So what should they consider in approaching the task? PwC has identified six key areas for attention.